Effect of ozanimod on circulating leukocyte subtypes: Data from a randomised, open-label, phase 1 study in patients with relapsing multiple sclerosis

Authors
Category Primary study
ConferenceMultiple Sclerosis Journal
Year 2019
This article has no abstract
Epistemonikos ID: 36fc76da6a1bbc381f411c8cb87742a93cb83e46
First added on: Apr 29, 2026